Clinical Kidney Journal

Article	Citations
An introduction to inverse probability of treatment weighting in observational research	182
Coronavirus disease 2019 in chronic kidney disease	57
Conducting correlation analysis: important limitations and pitfalls	55
The ERA Registry Annual Report 2019: summary and age comparisons	54
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis	46
RICORS2040: the need for collaborative research in chronic kidney disease	45
Bone mineral density and mortality in end-stage renal disease patients	35
Fiber intake and health in people with chronic kidney disease	33
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	33
Kidney disease and electrolytes in COVID-19: more than meets the eye	33
Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients	32
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose	29
Oxalate nephropathy: a review	28
Epidemiology and burden of chronic kidney disease-associated pruritus	27
Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine	26
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study	26
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019	25
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects	25
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care	24
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant	23
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease	21
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics	21
Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019	21
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches	21
Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4	20

De novo and relapsing necrotizing vasculitis after COVID-19 vaccination	20
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination	19
Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls	19
Acute kidney injury in COVID-19: multicentre prospective analysis of registry data	19
Unravelling the pathophysiology of chronic kidney disease-associated pruritus	19
Hypophosphatemia in cancer patients	18
Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury	17
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	17
Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients	16
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	16
Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation	16
Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study	16
Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation	15
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis	15
Point-of-care testing technologies for the home in chronic kidney disease: a narrative review	15
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure	15
The Latin American Dialysis and Renal Transplantation Registry: report 2019	15
Comparison of four medium cut-off dialyzers	15
Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives	14
Correlations, agreement and utility of frailty instruments in prevalent haemodialysis patients: baseline cohort data from the FITNESS study	14
The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management	14
The rapid development of a novel kidney-specific digital intervention for self-management of physical activity and emotional well-being during the COVID-19 pandemic and beyond: Kidney Beam	14
The Many Faces of NELL1 MN	14
Primary hyperoxaluria type 1: pathophysiology and genetics	14
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination	14
Albumin is an interface between blood plasma and cell membrane, and not just a sponge	14
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice	14
Multitargeted interventions to reduce dialysis-induced systemic stress	14
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination	13
Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria	13
Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study	13
Targeting complement in severe coronavirus disease 2019 to address microthrombosis	13
Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study	13
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	13
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis	12
Outcomes and predictors of skin sodium concentration in dialysis patients	12
More on the invisibility of chronic kidney disease… and counting	12
Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans	12
Treatment of primary hyperoxaluria type 1	12
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art	12
Primary hyperoxaluria type 1: novel therapies at a glance	12
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy	12
Early and late acute kidney injury: temporal profile in the critically ill pediatric patient	12
Tirzepatide and prevention of chronic kidney disease	12
Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved	12
Blood pressure targets in CKD 2021: the never-ending guidelines debacle	12
The utility of remote patient management in peritoneal dialysis	12
Association of leukocyte telomere length with chronic kidney disease in East Asians with type 2 diabetes: a Mendelian randomization study	12
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study	11
Nicotinamide and acute kidney injury	11

Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics	11
Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines	11
Decreasing microbiota-derived uremic toxins to improve CKD outcomes	11
The ERA Registry Annual Report 2020: a summary	11
Development and external validation of an acute kidney injury risk score for use in the general population	11
Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients	11
Randomized comparison of three high-flux dialyzers during high-volume online hemodiafiltration—the comPERFORM study	10
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients	10
Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patients	10
ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature	10
Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach	10
Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study	10
Robot-assisted kidney transplantation: an update	10
Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction	10
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	10
Development and internal validation of a Wasp Sting Severity Score to assess severity and indicate blood purification in persons with Asian wasp stings	10
Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease	10
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study	10
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation	10
Contemporary outcomes of anemia in US patients with chronic kidney disease	9
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy	9
New and old GFR equations: a European perspective	9
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients	9
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	9
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease	9
Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?	9
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence	9
The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases	9
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine	9
Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease	9
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors	9
Adult-onset nephrotic syndrome following coronavirus disease vaccination	9
Frailty among chronic kidney disease patients on the kidney transplant waiting list: the sex–frailty paradox	9
The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review	9
Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study	9
The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years	9
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	9
Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine	8
Thiazide diuretics are back in CKD: the case of chlorthalidone	8
Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis	8
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy	8
Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients	8
Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab	8
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes	8
Acute interstitial nephritis following SARS-CoV-2 vaccination	8
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain	8
Acute interstitial nephritis after messenger RNA-based vaccination	8
Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data	8
Operational considerations for peritoneal dialysis management during the COVID-19 pandemic	8
Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease	8
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	8
New aspects in cardiorenal syndrome and HFpEF	8
A functional TGFB1 polymorphism in the donor associates with long-term graft survival after kidney transplantation	8
Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease	8
Increased LDL-cholesterol level is associated with deterioration of renal function in males	8
Management of fracture risk in CKD—traditional and novel approaches	8
Influence of doctors’ perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China	8
Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study	8
Immune abnormalities in IgA nephropathy	8
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't	7
PoCUS in nephrology: a new tool to improve our diagnostic skills	7
Ageing meets kidney disease	7
Peritoneal dialysis–first initiative in India: a cost-effectiveness analysis	7
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases	7
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction	7
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study	7
Outcomes of patients with COVID-19 on kidney replacement therapy: a comparison among modalities in England	7
Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?	7
Higher ambient nitrogen dioxide is associated with an elevated risk of hospital-acquired acute kidney injury	7
Expanded hemodialysis: what’s up, Doc?	7
Stability and compatibility of antibiotics in peritoneal dialysis solutions	7
Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification	7
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review	7
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	7
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia	7
Comparative efficacy of patiromer and sodium polystyrene sulfonate on potassium levels in chronic haemodialysis patients: a randomized crossover trial	7
Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study	7
Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis	7
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Associatio	7
Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease	7

Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic	7
Treatment of acute kidney injury in cancer patients	7
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patient	7
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression	7
Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort stud	7
Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function	6
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs	6
Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination	6
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis	6
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	6
The misuse of funnel plots in meta-analyses of proportions: are they really useful?	6
The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury	6
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	6
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	6
Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort study	6
Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care	6
Subtyping hospitalized patients with hypokalemia by machine learning consensus clustering and associated mortality risks	6
In vitro elimination of anti-infective drugs by the Seraph® 100 Microbind® affinity blood filter	6
Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey	6
An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits	6
Long-term impact of COVID-19 among maintenance haemodialysis patients	6
Pseudo-acute kidney injury secondary to tepotinib	6
Achieving consensus on psychosocial and physical rehabilitation management for people living with kidney disease	6
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	6
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D	6
The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait	6
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease	6
The scientific principles and technological determinants of haemodialysis membranes	6
The membrane perspective of uraemic toxins: which ones should, or can, be removed?	6
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?	6
Women's representation in clinical trials of patients with chronic kidney disease	6
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort	6
First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2	6
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?	6
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin	6
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease	6
A roadmap to parathyroidectomy for kidney transplant candidates	6
Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease	5
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study	5
Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study	5
Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment	5
Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine	5
Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients	5
Deprivation and chronic kidney disease—a review of the evidence	5
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	5
Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against haemodialysis patients	5
Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury	5
Systematic reporting of medical kidney biopsies	5
Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events	5
Increased mortality after kidney transplantation in mildly frail recipients	5
Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?	5
Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	5
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy	5
Probiotics for kidney disease	5
Future landscape for the management of membranous nephropathy	5
Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model	5
Integrating electronic health data records to develop and validate a predictive model of hospital-acquired acute kidney injury in non-critically ill patients	5
How to manage cigarette smoking in kidney transplant candidates and recipients?	5
A treasure from a barren island: the discovery of rapamycin	5
2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis	5
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor	5
Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era	5
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease	5
Semaglutide for treatment of obesity in hemodialysis patients waiting for a kidney transplant: new hope?	5
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury	5
Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population	5
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	5
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients	5
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry	5
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications	5
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	5
Native BK virus nephropathy in lung transplant: a case report and literature review	5
Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus	5
Severe acute respiratory SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience	5
Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis	5
Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort	5
The association of glucose metabolism and kidney function in middle-aged adults	5
Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review	5
Serum bilirubin and kidney function: a Mendelian randomization study	5
Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome	5
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients	5
The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis	5